07 Jan 2001

Concor® COR (Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Concor® COR 1,25 mg | -2,5 mg | -3,75 mg | -5 mg | -7,5 mg | -10 mg

Stabile chronische mittelgradige bis schwere Herzinsuffizienz bei eingeschränkter systolischer Ventrikelfunktion (EF zu ACE-Hemmern u. Diuretika, u. optional Herzglykosiden.

Concor® COR Description, Presentation and Dosage

Concor® COR Description

Concor® COR Drug Class Description


Concor® COR Drug Description

1 Filmtbl. enth.: Bisoprololhemifumarat 1,25 mg/2,5 mg/3,75 mg/5 mg/7,5 mg/10 mg.

Concor® COR Generic Name

Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg Filmtabletten

Concor® COR Presentation

Concor® COR Presentation

Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg

Concor® COR Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Concor® COR Dosage

Concor® COR Adult Dosage

Hochdisperses Siliciumdioxid, Magnesiumstearat, Crospovidon, mikrokristalline Cellulose, Maisstärke, Calciumhydrogenphosphat, Dimeticon, Macrogol 400, E 171, Hypromellose, -1,25 mg zusätzl.: vorverkleisterte Stärke, -3,75 mg/-5 mg/-7,5 mg/-10 mg zusätzl.: E 172.

Concor® COR Precautions, Reactions and Contraindications

Concor® COR Special Precautions

Concor® COR Special Precautions

B 22 b-c, e-j. Akute od. dekomp. Herzinsuff. die i.v. Ther. m. inotropen Substanzen erfordert. Bradykardie (

Related Drugs - Cardiology

Back to top